Could a vending Machine-Style kiosk curb HIV and overdose deaths in rural america?
NCT ID NCT05657106
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a special kiosk placed in rural Appalachian Kentucky that provides clean syringes and harm reduction supplies to people who inject drugs. The goal is to see if the kiosk helps reduce the spread of HIV and hepatitis C, and lowers the risk of drug overdose. About 752 adults who have used illicit drugs in the past 6 months are taking part across two counties.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Harm reduction kiosk (behavioral intervention)
What this could lead to
If successful, this kiosk could provide a practical way to reduce HIV, hepatitis C, and overdose deaths in rural areas with limited access to harm reduction services.
What could go wrong
This is a behavioral intervention study, not a drug trial, so results may vary by community. The kiosk may not reach all at-risk individuals or significantly change long-term risk behaviors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAVENOUS DRUG USAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky
Lexington, Kentucky, 40506, United States